Silica vesicle nanovaccine formulations stimulate long-term immune responses to the bovine viral diarrhoea virus e2 protein

HIGHLIGHTS

• who: Karishma T. Mody and colleagues from the Queensland Alliance for Agriculture and Food Innovation, The University of Queensland, Brisbane, Australia have published the Article: Silica Vesicle Nanovaccine Formulations Stimulate Long-Term Immune Responses to the Bovine Viral Diarrhoea Virus E2 Protein, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0143507]. December 2, 2015 of /1371/
• what: [14] To further develop SVs as vaccine nanocarriers which are self-adjuvanting, the first goal of this study was to determine if the oE2/SV140 formulation previously shown to be effective in generating antibody and cell . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.